Rebecca E. McMahon - 17 Mar 2023 Form 4 Insider Report for Sanara MedTech Inc. (SMTI)

Reporting relationship: President - R&D
Issuer ticker: SMTI
Reported as of: 17 Mar 2023
Net transaction value: -$8,342
SEC form: 4
Accepted by SEC: 21 Mar 2023, 16:15:32 UTC
Prior SEC filing: 06 Mar 2023
Source filing: View source filing
Reporting owner signature: /s/ Rebecca E. McMahon

Key filing fact

Rebecca E. McMahon filed Form 4 for Sanara MedTech Inc. (SMTI) on 21 Mar 2023.

Key facts

This page summarizes Rebecca E. McMahon's Form 4 filing for Sanara MedTech Inc. (SMTI).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 21 Mar 2023, 16:15.

Change

Previous filing in this sequence was filed on 06 Mar 2023.
Current net transaction value: -$8,342.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

SMTI transaction

Common Stock

Tax liability

Transaction value: $8,342
Shares: -201
Change %: -2.1%
Price: $41.50
Shares after: 9,595
Date: 17 Mar 2023
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Represents shares of common stock of Sanara MedTech Inc. (the "Issuer") withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of 682 shares of restricted stock granted to the reporting person on March 8, 2022. No shares were issued or sold in this transaction. The per-share value assigned to the shares withheld reflects the price per share on the date on which the shares vested as reported on the Nasdaq Capital Market.